Takada Y, Ozawa K, Yamaoka Y, Uemoto S, Tanaka A, Morimoto T, Honda K, Shimahara Y, Mori K, Inamoto T
Second Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Transplantation. 1993 Jun;55(6):1314-9. doi: 10.1097/00007890-199306000-00020.
Changes in the arterial ketone body ratio (AKBR [acetoacetate/3-hydroxybutyrate]), which reflect the redox state of the liver mitochondria (NAD+/NADH), as well as those in total ketone body concentration (TKB) and blood glucose level were studied in 30 living-related liver transplantations (LRLT) performed in pediatric patients at Kyoto University Hospital from June 1990 to January 1992. AKBR increased to over 1.0 within 6 hr after reperfusion of the graft in 11 cases (37%), within 12 hr in 7 (23%), on POD 1 in 8 (27%), and on POD 2 in the remaining 4 cases (13%). TKB significantly increased while AKBR remained below 0.7 (266 +/- 40 mumol/L), but it significantly decreased in accordance with the recovery of AKBR above 1.0 (61 +/- 6 mumol/L). This indicates the change in the predominant energy substrate for hepatic mitochondria from fatty acid to glucose during the AKBR recovery process. In 6 cases, the AKBR transiently decreased to below 1.0 after initial recovery concomitant with the fall in blood glucose level and the increase in TKB. However, the AKBR was rapidly restored to over 1.0 again immediately after the glucose administration was increased. This suggests that glucose administration to maintain blood glucose level between 150 and 250 mg/dl is essential for the AKBR recovery above 1.0 that accompanies the normalization of graft metabolic functions, and that, along with the postoperative minimal increase in serum enzymes and favorable outcome of the transplant with no incidence of a primary nonfunctioning graft, the prompt and successful recovery of AKBR reflects the expected high viability of the graft in our LRLT cases.
1990年6月至1992年1月期间,在京都大学医院对30例小儿活体肝移植(LRLT)患者进行了研究,观察反映肝线粒体氧化还原状态(NAD+/NADH)的动脉酮体比率(AKBR [乙酰乙酸/3-羟基丁酸])、总酮体浓度(TKB)和血糖水平的变化。11例患者(37%)在移植肝再灌注后6小时内AKBR升至1.0以上,7例(23%)在12小时内,8例(27%)在术后第1天,其余4例(13%)在术后第2天。当AKBR低于0.7(266±40μmol/L)时TKB显著升高,但随着AKBR恢复至1.0以上(61±6μmol/L)TKB显著下降。这表明在AKBR恢复过程中,肝线粒体的主要能量底物从脂肪酸转变为葡萄糖。6例患者在最初恢复后AKBR短暂降至1.0以下,同时血糖水平下降,TKB升高。然而,在增加葡萄糖给药后,AKBR立即迅速恢复至1.0以上。这表明维持血糖水平在150至250mg/dl之间对于AKBR恢复至1.0以上至关重要,而AKBR的恢复伴随着移植肝代谢功能的正常化,并且与术后血清酶的最小升高以及移植成功且无原发性无功能移植的发生情况一起,AKBR的迅速且成功恢复反映了我们LRLT病例中移植肝预期的高活力。